Janus Global Life Sciences T (JAGLX)
* As of 31-Mar-14
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for JAGLX at this time.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||0.94%|
Performance & Risk
|5y Avg Return:||26.09%|
|Rank in Category (ytd):||26|
|% Rank in Category (ytd):||19.85%|
|Morningstar Risk Rating:||3|
The investment seeks long-term growth of capital.
The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector. View More